Bob Holmen

Insider Reports History

Location
1405 Research Blvd., Ste. 125, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bob Holmen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. Director Stock Option (Right to Buy) 19K May 21, 2025 Direct

Insider Reports Filed by Bob Holmen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. May 21, 2025 1 $0 4 May 23, 2025 Director
SNSE Sensei Biotherapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
SNSE Sensei Biotherapeutics, Inc. Jul 10, 2023 2 $0 4 Jul 12, 2023 Director
SNSE Sensei Biotherapeutics, Inc. Jun 10, 2022 2 $0 4 Jun 14, 2022 Director